Cargando…

Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report

Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70‐year‐old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right...

Descripción completa

Detalles Bibliográficos
Autores principales: Yukawa, Takuro, Ishida, Yuta, Naomoto, Yoshio, Monobe, Yasumasa, Fukazawa, Takuya, Yamatsuji, Tomoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013649/
https://www.ncbi.nlm.nih.gov/pubmed/35301802
http://dx.doi.org/10.1111/1759-7714.14374
_version_ 1784688040560558080
author Yukawa, Takuro
Ishida, Yuta
Naomoto, Yoshio
Monobe, Yasumasa
Fukazawa, Takuya
Yamatsuji, Tomoki
author_facet Yukawa, Takuro
Ishida, Yuta
Naomoto, Yoshio
Monobe, Yasumasa
Fukazawa, Takuya
Yamatsuji, Tomoki
author_sort Yukawa, Takuro
collection PubMed
description Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70‐year‐old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right middle lobe hypoplasia. He subsequently underwent right upper and middle lobectomy with lymph node dissection by video‐assisted thoracoscopic surgery. In addition to an invasive adenocarcinoma in the right upper lobe, pathological examination of the hypoplastic lobe revealed neuroendocrine hyperplasia, as well as tumorlets and a typical carcinoid. Eight cases of pulmonary neuroendocrine tumors that developed from pulmonary hypoplasia have been reported to date. Interestingly, all but one case occurred in the right middle lobe. Neuroendocrine cell hyperplasia has been reported to develop in hypoplastic lungs postnatally; therefore, we speculated that the lesion was the origin of these neuroendocrine tumors. Moreover, the pathological findings suggested that atelectasis was involved in the pathogenesis of this rare condition. In adults, when lobar hypoplasia is diagnosed, neuroendocrine tumors should be anticipated.
format Online
Article
Text
id pubmed-9013649
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-90136492022-04-20 Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report Yukawa, Takuro Ishida, Yuta Naomoto, Yoshio Monobe, Yasumasa Fukazawa, Takuya Yamatsuji, Tomoki Thorac Cancer Case Reports Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70‐year‐old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right middle lobe hypoplasia. He subsequently underwent right upper and middle lobectomy with lymph node dissection by video‐assisted thoracoscopic surgery. In addition to an invasive adenocarcinoma in the right upper lobe, pathological examination of the hypoplastic lobe revealed neuroendocrine hyperplasia, as well as tumorlets and a typical carcinoid. Eight cases of pulmonary neuroendocrine tumors that developed from pulmonary hypoplasia have been reported to date. Interestingly, all but one case occurred in the right middle lobe. Neuroendocrine cell hyperplasia has been reported to develop in hypoplastic lungs postnatally; therefore, we speculated that the lesion was the origin of these neuroendocrine tumors. Moreover, the pathological findings suggested that atelectasis was involved in the pathogenesis of this rare condition. In adults, when lobar hypoplasia is diagnosed, neuroendocrine tumors should be anticipated. John Wiley & Sons Australia, Ltd 2022-03-17 2022-04 /pmc/articles/PMC9013649/ /pubmed/35301802 http://dx.doi.org/10.1111/1759-7714.14374 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yukawa, Takuro
Ishida, Yuta
Naomoto, Yoshio
Monobe, Yasumasa
Fukazawa, Takuya
Yamatsuji, Tomoki
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
title Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
title_full Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
title_fullStr Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
title_full_unstemmed Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
title_short Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
title_sort neuroendocrine tumor secondary to pulmonary hypoplasia: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013649/
https://www.ncbi.nlm.nih.gov/pubmed/35301802
http://dx.doi.org/10.1111/1759-7714.14374
work_keys_str_mv AT yukawatakuro neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport
AT ishidayuta neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport
AT naomotoyoshio neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport
AT monobeyasumasa neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport
AT fukazawatakuya neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport
AT yamatsujitomoki neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport